Dyspepsia Completed Phase 4 Trials for Berberine (DB04115)

Also known as: Indigestion

IndicationStatusPhase
DBCOND0004526 (Dyspepsia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02296021Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple TherapyTreatment
NCT02633930Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple TherapyTreatment